醫療用EDI的歐洲市場:各供應商 (經銷商、批發商，GPO，廠商)、購買組織 (醫院、GPO)、交易
European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration
|出版日期||內容資訊||英文 69 Pages
|醫療用EDI的歐洲市場:各供應商 (經銷商、批發商，GPO，廠商)、購買組織 (醫院、GPO)、交易 European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration|
|出版日期: 2016年07月21日||內容資訊: 英文 69 Pages||
EDI provides fast, secure, and easy exchange of information between healthcare organizations. These advantages coupled with the growing competitiveness, rising adoption of mobile EDI, pricing pressure, and lower profit margins are driving greater uptake of EDI solutions among pharmaceutical companies and medical device manufacturers in Europe. However, high cost of EDI implementation, lack of infrastructure, and EDI management issues are restrict the overall growth of the market.
The increasing adoption of EDI solutions among hospitals, operational benefits and increased speed of transaction processing, and growing utilization of EDI solutions in supply chain management are the factors contributing to the growth of healthcare EDI market in Europe. Bayer AG, Pfizer Inc., GlaxoSmithKline PLC, and Abbott Laboratories are the EDI technology leaders in the European pharmaceutical and manufacturing sector.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers: